Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Proposal for Human Respiratory Syncytial Virus Nomenclature Below the Species Level Publisher Pubmed



Salimi V1 ; Viegas M2 ; Trento A3 ; Agoti CN4 ; Anderson LJ5 ; Avadhanula V6 ; Bahl J7 ; Bont L8 ; Brister JR9 ; Cane PA10 ; Galiano M10, 11 ; Graham BS12 ; Hatcher EL9 ; Hellferscee O13 Show All Authors
Authors
  1. Salimi V1
  2. Viegas M2
  3. Trento A3
  4. Agoti CN4
  5. Anderson LJ5
  6. Avadhanula V6
  7. Bahl J7
  8. Bont L8
  9. Brister JR9
  10. Cane PA10
  11. Galiano M10, 11
  12. Graham BS12
  13. Hatcher EL9
  14. Hellferscee O13
  15. Henke DM6
  16. Hirve S14
  17. Jackson S14
  18. Keyaerts E15
  19. Kragtentabatabaie L16, 17
  20. Lindstrom S18
  21. Nauwelaers I10, 19
  22. Nokes DJ4
  23. Openshaw PJ19
  24. Peret TC18
  25. Piedra PA6
  26. Ramaekers K20
  27. Rector A20
  28. Trovao NS21
  29. Von Gottberg A13
  30. Zambon M10
  31. Zhang W14
  32. Williams TC22
  33. Barr IG23
  34. Buchholz UJ12
Show Affiliations
Authors Affiliations
  1. 1. Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Hospital de Ninos Dr. Ricardo Gutierrez, Buenos Aires, Argentina
  3. 3. National Center of Biotechnology, Madrid, Spain
  4. 4. KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  5. 5. Emory University, Atlanta, GA, United States
  6. 6. Baylor College of Medicine, Houston, TX, United States
  7. 7. University of Georgia, Athens, GA, United States
  8. 8. University Medical Center, Utrecht, Netherlands
  9. 9. National Center for Biotechnology Information, Bethesda, MD, United States
  10. 10. Public Health England, London, United Kingdom
  11. 11. Francis Crick Institute, London, United Kingdom
  12. 12. National Institute of Allergy and Infectious Diseases, Bethesda, United States
  13. 13. National Institute for Communicable Diseases, The National Health Laboratory Service, Johannesburg, South Africa
  14. 14. World Health Organization, Geneva, Switzerland
  15. 15. University Hospitals Leuven, Leuven, Belgium
  16. 16. ReSViNET Foundation, Zeist, Netherlands
  17. 17. Julius Clinical, Zeist, Netherlands
  18. 18. Centers for Disease Control and Prevention, Atlanta, United States
  19. 19. Imperial College London, London, United Kingdom
  20. 20. Rega Institute, Leuven, Belgium
  21. 21. Fogarty International Center, Bethesda, United States
  22. 22. University of Edinburgh, Edinburgh, United Kingdom
  23. 23. Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia

Source: Emerging Infectious Diseases Published:2021


Abstract

Human respiratory syncytial virus (HRSV) is the leading viral cause of serious pediatric respiratory disease, and lifelong reinfections are common. Its 2 major subgroups, A and B, exhibit some antigenic variability, enabling HRSV to circulate annually. Globally, research has increased the number of HRSV genomic sequences available. To ensure accurate molecular epidemiology analyses, we propose a uniform nomenclature for HRSV-positive samples and isolates, and HRSV sequences, namely: HRSV/subgroup identifier/geographic identifier/unique sequence identifier/year of sampling. We also propose a template for submitting associated metadata. Universal nomenclature would help researchers retrieve and analyze sequence data to better understand the evolution of this virus. © 2021 Centers for Disease Control and Prevention (CDC). All rights reserved.
Other Related Docs
11. Viral Respiratory Infections in Patients With Cancer, International Journal of Cancer Management (2017)
17. Prevalence of Human Respiratory Syncytial Virus Circulating in Iran, Journal of Infection and Public Health (2016)